SLC12A5 and glioma: We then evaluated the effect of IHMT-337 on glioma cell migration, revealing a significant inhibition of cell migration promoted by EZH2 overexpression (Fig. 5f), as well as the suppression of cell migration induced by KCC2 downregulation (Fig. 5g).